98% Erigeron Breviscapus Extract Breviscapine Scutellarin Powder

a. Reduce myocardial oxygen consumption, to increase nutrition myocardial blood flow, improve myocardial microcirculation;

b. Improve cerebral blood circulation, increase cerebral blood flow,reducing vascular resistance, increase the permeability of the blood-brain barrier,conducive to the prevention and treatment of cerebral thrombosis formation;

c. Increase the phagocytic function of the liver reticuloendothelial cells and macrophages and blood CAMP content, improve the immune system;

d. Inhibition of intravascular coagulation, fibrinolysis promoting, reducing fibrinogen, and anti-tied thrombolysis;

 

 

Breviscapine has the effect of dilating cerebral blood vessels, can reduce cerebrovascular resistance, increase cerebral blood flow, improve microcirculation, and have the effect of resisting platelet aggregation. Therefore, it can be used for the treatment of ischemic cerebrovascular diseases, such as cerebral thrombosis, cerebral embolism, cerebral hemorrhage and other paralyzed patients with sequelae. It has better curative effect, and the curative effect on the course of disease within 6 months is better than that of patients over 6 months. It is an oral tablet refined from the flavonoid active ingredient breviscapine from the whole plant of Erigeron-Guizhou Plateau. Mainly have anticoagulant, anti-thrombosis, improve blood rheology and microcirculation, increase cerebral blood flow, resist myocardial ischemia, and improve the body's ability to withstand hypoxia.